SUTRO BIOPHARMA, INC. financial data

Symbol
STRO on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 254% % -32%
Debt-to-equity -1274% % -599%
Return On Equity 862% %
Return On Assets -73% % -169%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 85,135,290 shares 3.2%
Common Stock, Shares, Outstanding 85,101,749 shares 3.3%
Entity Public Float $237,800,000 USD -15%
Common Stock, Value, Issued $85,000 USD 3.7%
Weighted Average Number of Shares Outstanding, Basic 84,869,864 shares 3.4%
Weighted Average Number of Shares Outstanding, Diluted 84,869,864 shares 3.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $105,646,000 USD -34%
Research and Development Expense $200,812,000 USD -14%
General and Administrative Expense $41,387,000 USD -26%
Operating Income (Loss) $185,576,000 USD -43%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $56,857,000 USD -17%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $216,767,000 USD -75%
Earnings Per Share, Basic -2 USD/shares -133%
Earnings Per Share, Diluted -2 USD/shares -133%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $65,927,000 USD -62%
Marketable Securities, Current $101,667,000 USD -52%
Accounts Receivable, after Allowance for Credit Loss, Current $3,922,000 USD -41%
Assets, Current $182,113,000 USD -55%
Property, Plant and Equipment, Net $13,346,000 USD -30%
Operating Lease, Right-of-Use Asset $13,341,000 USD -30%
Other Assets, Noncurrent $0 USD -100%
Assets $209,658,000 USD -54%
Accounts Payable, Current $7,034,000 USD 13%
Accrued Liabilities, Current $13,248,000 USD 0.54%
Contract with Customer, Liability, Current $8,977,000 USD -88%
Liabilities, Current $71,895,000 USD -45%
Contract with Customer, Liability, Noncurrent $3,758,000 USD -79%
Operating Lease, Liability, Noncurrent $9,701,000 USD -45%
Other Liabilities, Noncurrent $1,694,000 USD 0%
Liabilities $296,926,000 USD -13%
Accumulated Other Comprehensive Income (Loss), Net of Tax $33,000 USD -69%
Retained Earnings (Accumulated Deficit) $931,193,000 USD -30%
Stockholders' Equity Attributable to Parent $87,268,000 USD -178%
Liabilities and Equity $209,658,000 USD -54%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $67,883,000 USD -4.9%
Net Cash Provided by (Used in) Financing Activities $66,000 USD
Net Cash Provided by (Used in) Investing Activities $16,258,000 USD -125%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 85,101,749 shares 3.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $84,075,000 USD -1968%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $66,785,000 USD -62%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $227,831,000 USD 36%
Deferred Tax Assets, Gross $231,653,000 USD 28%
Operating Lease, Liability $17,661,000 USD -29%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $216,840,000 USD -75%
Lessee, Operating Lease, Liability, to be Paid $19,707,000 USD -32%
Property, Plant and Equipment, Gross $66,820,000 USD 4.2%
Operating Lease, Liability, Current $7,960,000 USD 11%
Lessee, Operating Lease, Liability, to be Paid, Year Two $8,289,000 USD -7.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $8,994,000 USD -5.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,046,000 USD -52%
Lessee, Operating Lease, Liability, to be Paid, Year Three $8,289,000 USD -7.8%
Deferred Tax Assets, Operating Loss Carryforwards $39,662,000 USD 6.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $12,057,000 USD 38%
Operating Lease, Payments $2,300,000 USD 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $1,900,000 USD 7.9%
Deferred Tax Assets, Net of Valuation Allowance $3,822,000 USD -71%
Share-based Payment Arrangement, Expense $18,268,000 USD -27%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%